Skip to product information
1 of 1

Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb (S-3861)

Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb (S-3861)

Catalog Number: S0B6546 Application: WB, ICC Reactivity: Human,Mouse, Rat, Monkey Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Phospho-p38 MAPK (Thr180/Tyr182)
Synonyms Mitogen-activated protein kinase 14, MAP kinase 14, MAPK14, CSAID-binding protein, CSBP, MAP kinase MXI2, MAX-interacting protein 2, MAP kinase p38 alpha, SAPK2a
Location Cytoplasm, Nucleus
Accession Q16539
Clone Number S-3861
Antibody Type Recombinant mAb
Isotype IgG
Application WB, ICC
Reactivity Hu, Ms, Rt, Mk
Positive Sample anisomycin treated Jurkat, anisomycin treated NIH/3T3, anisomycin treated C6, anisomycin treated COS-7
Predicted Reactivity Dm, Pg, Sc
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms, Rt, Mk
ICC 1:500 Hu

Background

Phospho-p38 MAPK (Thr180/Tyr182) refers to the active form of the p38 mitogen-activated protein kinase that is dually phosphorylated at threonine 180 (Thr180) and tyrosine 182 (Tyr182) within its activation loop. As a central component of the cellular stress response signaling pathway, p38 MAPK is often termed the "stress-activated protein kinase." When cells are exposed to external stressors such as oxidative stress, osmotic shock, UV radiation, or inflammatory cytokines, upstream kinases (e.g., MKK3/MKK6) specifically recognize and phosphorylate these two residues. This dual phosphorylation induces a conformational change in the p38 protein, leading to its full activation. The activated Phospho-p38 MAPK then translocates from the cytoplasm to the nucleus, where it phosphorylates a series of downstream transcription factors (e.g., ATF-2, CHOP, MEF2) and other kinases, ultimately regulating critical biological processes including inflammatory responses, apoptosis, differentiation, autophagy, and cell cycle arrest. Consequently, detecting the level of Phospho-p38 MAPK (Thr180/Tyr182) serves as the most direct and crucial molecular indicator for assessing the activation status of the p38 MAPK pathway within cells, and it is widely utilized in fields such as immunology, neuroscience, cancer research, and drug development.

Picture

Western Blot

WB result of Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated Jurkat whole cell lysate 20 µg
Lane 2: Jurkat treated with 25 µg/ml anisomycin for 20 minutes whole cell lysate 20 µg 
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 41 kDa
Observed MW: 38 kDa

WB result of Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated C6 whole cell lysate 20 µg
Lane 2: C6 treated with 25 µg/ml anisomycin for 20 minutes whole cell lysate 20 µg 
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 41 kDa
Observed MW: 38 kDa

WB result of Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated NIH/3T3 whole cell lysate 20 µg
Lane 2: NIH/3T3 treated with UV (50 mJ/cm2, 30 minutes recovery) whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 41 kDa
Observed MW: 38 kDa

WB result of Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-p38 MAPK (Thr180/Tyr182) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated COS-7 whole cell lysate 20 µg
Lane 2: COS-7 treated with UV (50 mJ/cm2, 30 minutes recovery) whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 41 kDa
Observed MW: 38 kDa

Immunocytochemistry

ICC analysis of HeLa cells treated with anisomycin(25ug/ml,20mins) (top panel) and untreated HeLa cells (below panel). Anti- Phospho-p38 MAPK (Thr180/Tyr182) antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).